Search Results - "Bruggink, A H"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Incidence of eosinophilic esophagitis in the Netherlands continues to rise: 20‐year results from a nationwide pathology database by Warners, M. J., Rooij, W., Rhijn, B. D., Verheij, J., Bruggink, A. H., Smout, A. J. P. M., Bredenoord, A. J.

    Published in Neurogastroenterology and motility (01-01-2018)
    “…Background The incidence of eosinophilic esophagitis (EoE) has increased rapidly. Most epidemiologic data were gathered in single‐center studies over a short…”
    Get full text
    Journal Article
  2. 2

    Stem cell-derived cardiomyocytes after bone marrow and heart transplantation by de Weger, R A, Verbrugge, I, Bruggink, A H, van Oosterhout, M M, de Souza, Y, van Wichen, D F, Gmelig-Meyling, F H J, de Jonge, N, Verdonck, L F

    Published in Bone marrow transplantation (Basingstoke) (01-03-2008)
    “…Cardiomyocytes are a stable cell population with only limited potential for renewal after injury. Tissue regeneration may be due to infiltration of stem cells,…”
    Get full text
    Journal Article
  3. 3

    T Cell Apoptosis in Human Heart Allografts : Association with Lack of Co-Stimulation? by Van Hoffen, Els, Van Wichen, Dick F, Leemans, Jaklien C, Broekhuizen, Richard A.J.F, Bruggink, Annette H, De Boer, Mark, De Jonge, Nicolaas, Kirkels, Hans, Slootweg, Piet J, Gmelig-Meyling, Frits H.J, De Weger, Roel A

    Published in The American journal of pathology (01-12-1998)
    “…It is unclear whether the intracardial immune reactivity after heart transplantation influences the peripheral immunological status (activation or…”
    Get full text
    Journal Article
  4. 4

    Overexpression of transforming growth factor-α and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters by Visser, C. J.T., Bruggink, A.H., Korc, M., Kobrin, M.S., de Weger, R.A., Seifert-Bock, I., van Blokland, W.T.M., van Garderen-Hoetmer, A., Woutersen, R.A.

    Published in Carcinogenesis (New York) (01-04-1996)
    “…Using immunohistochemistry, Northern blotting and a semi-quantitative PCR technique, epidermal growth factor (EGF), transforming growth factor-α (TGF-α) and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    TNFα in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device by Bruggink, A.H, van Oosterhout, M.F.M, De Jonge, N, Gmelig-Meyling, F.H.J, De Weger, R.A

    Published in Transplant immunology (01-04-2008)
    “…Abstract Background In the heart elevated levels of TNFα can cause lethal heart failure, like Dilated Cardiomyopathy (DCM). The level of TNFα production is in…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    No association between IL-10 promoter gene polymorphism and heart failure or rejection following cardiac transplantation by Bijlsma, F.J., Bruggink, A.H., Hartman, M., Gmelig-Meyling, F.H.J., Tilanus, M.G.J., De Jonge, N., De Weger, R.A.

    Published in Tissue antigens (01-02-2001)
    “…: Expression of interleukin (IL)‐10 influences the frequency of rejection events after organ transplantation. Therefore, 70 heart transplant patients were…”
    Get full text
    Journal Article
  10. 10

    TNFalpha in patients with end-stage heart failure on medical therapy or supported by a left ventricular assist device by Bruggink, A H, van Oosterhout, M F M, De Jonge, N, Gmelig-Meyling, F H J, De Weger, R A

    Published in Transplant immunology (01-04-2008)
    “…In the heart elevated levels of TNFalpha can cause lethal heart failure, like Dilated Cardiomyopathy (DCM). The level of TNFalpha production is in part…”
    Get full text
    Journal Article